ChemoCentryx, Inc. Share-based Payment Arrangement, Expense
ChemoCentryx, Inc. reported Share-based Payment Arrangement, Expense of $28.67 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2022-03-01
- ChemoCentryx, Inc. share-based payment arrangement, expense for the quarter ending 2018-12-31 was $1.97M, a 49.43% increase year-over-year.
- ChemoCentryx, Inc. share-based payment arrangement, expense for the quarter ending 2018-09-30 was $2.80M, a 47.37% increase year-over-year.
- ChemoCentryx, Inc. share-based payment arrangement, expense for the quarter ending 2017-12-31 was $1.32M.
- ChemoCentryx, Inc. share-based payment arrangement, expense for the quarter ending 2017-09-30 was $1.90M.
- ChemoCentryx, Inc. share-based payment arrangement, expense for fiscal 2021 was $28.67M, a 36.86% increase from fiscal 2020.
- ChemoCentryx, Inc. share-based payment arrangement, expense for fiscal 2020 was $20.95M, a 84.58% increase from fiscal 2019.
- ChemoCentryx, Inc. share-based payment arrangement, expense for fiscal 2019 was $11.35M, a 13.82% increase from fiscal 2018.
- ChemoCentryx, Inc. share-based payment arrangement, expense for fiscal 2018 was $9.97M, a 22.81% increase from fiscal 2017.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2021-12-31 | $28.67M 10-K · filed 2022-03-01 | |||
| 2020-12-31 | $20.95M 10-K · filed 2022-03-01 | |||
| 2019-12-31 | $11.35M 10-K · filed 2022-03-01 | |||
| 2018-12-31 | $1.97M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $4.77M derived: sum of 2 quarters · filed 2021-03-01 | $9.97M 10-K · filed 2021-03-01 | |
| 2018-09-30 | $2.80M 10-Q · filed 2018-11-08 | $8.00M 10-Q · filed 2018-11-08 | ||
| 2017-12-31 | $1.32M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $3.22M derived: sum of 2 quarters · filed 2020-03-10 | $8.12M 10-K · filed 2020-03-10 | |
| 2017-09-30 | $1.90M 10-Q · filed 2018-11-08 | $6.80M 10-Q · filed 2018-11-08 | ||
| 2016-12-31 | $8.22M 10-K · filed 2019-03-11 | |||
| 2015-12-31 | $8.86M 10-K · filed 2018-03-12 | |||
| 2014-12-31 | $7.96M 10-K · filed 2017-03-14 | |||
| 2013-12-31 | $6.09M 10-K · filed 2016-03-14 | |||
| 2012-12-31 | $4.81M 10-K · filed 2015-03-13 | |||
| 2012-09-30 | $13.70M 10-Q · filed 2012-11-13 | $19.60M derived: sum of 2 quarters · filed 2012-11-13 | ||
| 2012-06-30 | $5.90M 10-Q · filed 2012-08-10 | |||
| 2011-12-31 | $2.54M 10-K · filed 2014-03-14 | |||
| 2010-12-31 | $2.31M 10-K · filed 2013-03-14 |